Sedation for Cardioversion

Clinical trial of comparison the Effectiveness between Entonox and Midazolam-Fentanyl in Sedation for Cardioversion in patients with Tachydysrythmia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202269147N1

Enrollment

Registered

2014-05-13

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation for Cardioversion.

Interventions

Intervention 1: Control group sedated with Midazolam (0.15 milligrams per kilograms) plus Fentanyl (1.5 micrograms per kilograms). Intervention 2: Intervention group sedated with Entonox by demand val

Treatment - Drugs

Control group sedated with Midazolam (0.15 milligrams per kilograms) plus Fentanyl (1.5 micrograms per kilograms)

Intervention group sedated with Entonox by demand valve mask.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age over 18 years; symptomatic Tachydysrythmia Exclusion criteria: Drug sensitivity; pneumothorax; small bowel obstruction; chronic obstructive pulmonary disease; head trauma with decreased level of consciousness; Maxiofacial Injury; air emboli; inner ear infection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: After Sedation. Method of measurement: Visual Analogue Scale.;Sedation Level. Timepoint: During Sedation. Method of measurement: Richmond analgesia and sedation Scale.	—

Secondary

Measure	Time frame
Respiratory arrest. Timepoint: During sedation. Method of measurement: Patient Respiration observe.;More Doses. Timepoint: During sedation. Method of measurement: More than primery standard dose.;Time of Sedation. Timepoint: From onset of sedation untill return to primery level of consiousness. Method of measurement: Minutes.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Saghari

Ahvaz University of Medical Sciences

Saghari.s@ajums.ac.ir+98 61 1222 9166

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026